Drug disease interactions: role of inflammatory mediators in pain and variability in analgesic drug response by Kulmatycki, Kenneth M, Jamali, Fakhreddin

Get full text

Drug disease interactions: role of inflammatory mediators in disease and variability in drug response by Kulmatycki, Kenneth M, Jamali, Fakhreddin

Get full text

Drug disease interactions: role of inflammatory mediators in depression and variability in antidepressant drug response by Kulmatycki, Kenneth M, Jamali, Fakhreddin

Get full text

Iptacopan, a Novel Oral Complement Factor B (FB) Inhibitor, Significantly Reduces Proteinuria and C3 Deposit Scores in Native and Transplanted Kidneys C3 Glomerulopathy (C3G) Patie... by Wong, Edwin K., Nester, Carla M., escribano, Teresa Cavero, Karras, Alexandre, Lequintrec-Donnette, Moglie, Lightstone, Liz, Eisenberger, Ute, Soler, Maria Jose, Biondani, Andrea, Chaperon, Frederique, Kulmatycki, Kenneth M., Milojevic, Julie M., Nidamarthy, Prasanna Kumar, Webb, Nicholas, Junge, Guido, Remuzzi, Giuseppe

Get full text

Drug‐disease interactions: reduced β‐adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat by Kulmatycki, Kenneth M, Abouchehade, Kassem, Sattari, Saeed, Jamali, Fakhreddin

Get full text

THERAPEUTIC RELEVANCE OF ALTERED CYTOKINE EXPRESSION by Kulmatycki, Kenneth M., Jamali, Fakhreddin

Get full text

Abstract 12892: Safety and Efficacy of LHW090 in Patients With Resistant Hypertension: Results of a Randomized, Double Blind, Parallel Group, Placebo-Controlled Study by Yi, B Alexander, Huseinovic, Neda, Hom, Douglas, Mendonza, Anisha E, Kulmatycki, Kenneth M, Mogi, Muneto, Kunjathoor, Vidya V, Ruiz, Yaritza, Moest, Hansjoerg, Kinhikar, Arvind G, Luna, Blanca C, Gaskin, Tina, van den Born, Bert-Jan, Doerffel, Yvonne, Menne, Jan, Haller, Hermann, Smith, William B, Basson, Craig T

Get full text

Drug-disease interactions: reduced [beta]-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat by Kulmatycki, Kenneth M, Kassem Abouchehade, Sattari, Saeed, Jamali, Fakhreddin

Get full text

Considerations and recommendations for assessment of plasma protein binding and drug-drug interactions for siRNA therapeutics by Humphreys, Sara C, Davis, John A, Iqbal, Sajida, Kamel, Amin, Kulmatycki, Kenneth, Lao, Yanbin, Liu, Xiumin, Rodgers, John, Snoeys, Jan, Vigil, Adam, Weng, Yan, Wiethoff, Christopher M, Wittwer, Matthias B

Get full text

Efficacy and Safety of the CFTR Potentiator Icenticaftor (QBW251) in COPD: Results from a Phase 2 Randomized Trial by Rowe, Steven M, Jones, Ieuan, Dransfield, Mark T, Haque, Nazmul, Gleason, Stephen, Hayes, Katy A, Kulmatycki, Kenneth, Yates, Denise P, Danahay, Henry, Gosling, Martin, Rowlands, David J, Grant, Sarah S

Get full text

Safety and efficacy of the cystic fibrosis transmembrane conductance regulator potentiator icenticaftor (QBW251) by Kazani, Shamsah, Rowlands, David J., Bottoli, Ivan, Milojevic, Julie, Alcantara, Jose, Jones, Ieuan, Kulmatycki, Kenneth, Machineni, Surendra, Mostovy, Lidia, Nicholls, Ian, Nick, Jerry A., Rowe, Steven M., Simmonds, Nicholas J., Vegesna, Raju, Verheijen, Jeroen, Danahay, Henry, Gosling, Martin, Ayalavajjala, Phaninatha Sarma, Salman, Mohammed, Strieter, Robert

Get full text

Efficacy and Safety of the CFTR Potentiator Icenticaftor by Yates, Denise P, Haque, Nazmul, Jones, Ieuan, Gosling, Martin, Rowlands, David J, Dransfeld, Mark T, Gleason, Stephen, Grant, Sarah S, Kulmatycki, Kenneth, Rowe, Steven M, Hayes, Katy A, Danahay, Henry

Get full text